GSTM1 and ischemia: As depicted in Figure 8B, IL-10 treatment significantly improved cell viability (P < 0.05 vs. H2O2 + Hb under ischemia), indicating direct cardioprotection of IL-10 against ischemic injury in cardiomyocytes.